Stephanie Sellers

Dr. Stephanie Sellers is an assistant professor in the Division of Cardiology at the University of British Columbia (UBC) and a member of the divisions of cardiology at Vancouver General Hospital and St. Paul’s Hospital. Dr. Sellers directs the Centre for Cardiovascular Translational Science at the Dilawri Cardiovascular Institute (DCI) and co-leads MedTech Innovation at DCI. Supported by the Canadian Institutes of Health Research trainee awards, she completed her master’s at the University of Northern BC (Vascular Physiology), her PhD (Pharmacology & Therapeutics) and postdoctoral fellowship (Radiology) at UBC, during which she also trained at the University of Western Australia and Yale University.

As a vascular biologist, Dr. Sellers is a principal investigator at the UBC Centre for Heart Lung Innovation and UBC Centre for Cardiovascular Innovation. Her fundamental and translational research spans molecular biology, pathology, imaging and device evaluation, with a particular focus on the mechanisms of bioprosthetic valve degeneration, transcatheter heart valve durability and reintervention strategies. Dr. Sellers’ research group also leads a global registry and biobank of explanted transcatheter heart valves and partners with industry and academia to advance valve science.

Dr. Sellers is Michael Smith Health Research BC Scholar and the recipient of the 2023 UBC Department of Medine Martin M Hoffman Award for Excellence in Research, the 2024 UBC Faculty of Medicine Distinguished Achievement Award — Excellence in Basic Science Research and the 2025 St. Paul’s Hospital Department of Medicine Faculty Research Award. She authored over 150 peer-reviewed publications, received multiple national and international grants and holds editorial board appointments with JACC Case Reports, Cardiovascular Pathology, the Journal of the Heart Valve Society and Structural Heart.